Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Children With Recurrent Sarcomas
NCT00070109Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2008
- Primary completion
- Oct 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of trabectedin in rhabdomyosarcoma (RMS), Ewing sarcoma, soft tissue sarcoma (STS), sponsored by Children's Oncology Group. Started Jan 2008; status: completed.
02
Drugs
trabectedin
03
Conditions
rhabdomyosarcoma (RMS)Ewing sarcomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00070109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070109.